India Active Pharmaceutical Ingredients Market [2028]: Size, Share - Competitive Intelligence Report - TechSci ResearchPosted by Kumar on February 2nd, 2024 The India Active Pharmaceutical Ingredients (API) Market has emerged as a vital sector within the pharmaceutical industry, propelled by factors such as cost-effective manufacturing, strategic collaborations, and emerging disease threats. According to the latest research report by TechSci Research titled "India Active Pharmaceutical Ingredients Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028," the market witnessed a valuation of USD 17145.25 million in 2023 and is projected to exhibit robust growth with a CAGR of 8.87% through 2028. This comprehensive report delves into the intricacies of the market landscape, offering insights into key drivers, challenges, and opportunities shaping its trajectory. Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " India Active Pharmaceutical Ingredients Market” - https://www.techsciresearch.com/report/india-active-pharmaceutical-ingredients-market/7277.html Factors Driving Market Growth:
Strategic Initiatives and Market Developments: In April 2023, two Indian pharmaceutical companies, Natco Pharma and MacLeods Pharmaceuticals, announced their plans to release their versions of Johnson & Johnson's groundbreaking tuberculosis (TB) drug, Bedaquiline. This drug represents the first global approval for TB treatment in approximately four decades, offering a less toxic and more effective alternative to traditional treatments. The expiration of a key patent for this drug paved the way for Indian pharmaceutical companies to enter the market. Securing Emergency Use Authorization (EUA) and World Health Organization pre-qualification (PQ) status are crucial milestones in the adoption of the product by countries for their TB programs. Natco Pharma is involved in the production of both the API and the finished dosage form of Bedaquiline and is navigating regulatory clearances due to the unique nature of this drug. Challenges and Considerations:
The COVID-19 pandemic exposed vulnerabilities in global API supply chains, highlighting India's reliance on China for certain crucial ingredients. This has led to a renewed focus on "Atmanirbhar Bharat" (self-reliant India) in API production. Government schemes are attracting investments in domestic manufacturing, aiming to reduce import dependence and strengthen the industry's competitiveness. Segmentation and Regional Analysis:
The India Active Pharmaceutical Ingredients Market presents a dynamic landscape characterized by robust growth prospects, strategic collaborations, and emerging disease threats. Despite challenges such as regulatory compliance and complex supply chains, the market offers significant opportunities for stakeholders to capitalize on growing demand for cost-effective medications and innovative therapies. By leveraging insights from the comprehensive analysis provided in the TechSci Research report, industry players can navigate the evolving landscape of the API market and drive sustainable growth in the years to come. Download Free Sample Report - https://www.techsciresearch.com/sample-report.aspx?cid=7277 Customers can also request 10% free customization on this report Benefits of the Research Report:
Some of the major companies operating in the India Active Pharmaceutical Ingredients Market include:
“Certain areas, particularly in North America, are projected to exert significant demand for Active Pharmaceutical Ingredients. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the India Active Pharmaceutical Ingredients Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm. India Active Pharmaceutical Ingredients Market by Method of Synthesis (Synthetic, Biological, By Source (Contact Manufacturing Organizations, In-house Manufacturing), By Therapeutic Application (Cardiovascular Diseases, Anti-diabetic Drugs, Oncology Drugs, Neurological Disorders, Musculoskeletal Disorders, Others), By Drug Type (Generics, Innovator), By Region, By Competition Forecast & Opportunities, 2019-2028F has evaluated the future growth potential of India Active Pharmaceutical Ingredients Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Active Pharmaceutical Ingredients Market.
Download Free Sample Report - https://www.techsciresearch.com/sample-report.aspx?cid=7277
Contact Techsci Research- US - Techsci Research LLC 420 Lexington Avenue, Suite 300, New York, United States- 10170 Tel: +13322586602 Email: sales@techsciresearch.com
Like it? Share it!More by this author |